サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1563101

消化薬市場：世界の産業分析、規模、シェア、成長、動向、2024～2033年予測

Digestive Remedies Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日: | 発行: Persistence Market Research | ページ情報: 英文 300 Pages | 納期: 2～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.96円
消化薬市場：世界の産業分析、規模、シェア、成長、動向、2024～2033年予測
出版日: 2024年09月26日
発行: Persistence Market Research
ページ情報: 英文 300 Pages
納期: 2～5営業日
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Researchはこのほど、世界の消化薬市場に関する包括的なレポートを発表しました。当レポートでは、市場促進要因・動向・機会・課題を含む重要な市場力学を徹底的に評価し、市場構造に関する詳細な洞察を提供しています。

主要洞察

  • 消化薬市場規模（2024年）：197億3,186万1,000米ドル
  • 予測市場規模（2033年）：285億7,442万6,000米ドル
  • 世界市場成長率（CAGR 2024～2033年まで）：4.2 %

消化薬市場-調査範囲

消化薬には、消化不良、酸逆流、便秘、過敏性腸症候群（IBS）などの消化器系の健康問題の治療を目的とした幅広い製品が含まれます。市場は、制酸剤、下剤、下痢止め、プロバイオティクスなどの製品タイプ別、小売薬局、病院薬局、eコマースプラットフォームなどの最終用途セグメント別に区分されます。

市場促進要因：

世界の消化器系治療市場は、消化器系疾患や生活習慣病の増加により、市販（OTC）消化器系製品の需要が急増していることが牽引しています。腸の健康に対する消費者の意識の高まりとセルフメディケーション志向の高まりも、この市場の拡大を後押ししています。いくつかの地域では高齢化により消化器系の問題が発生しやすくなっており、消化器系治療の需要をさらに押し上げています。さらに、加工食品の消費の増加、座りがちなライフスタイル、ストレスが消化器系問題の有病率上昇に寄与しており、市場の成長を促進しています。また、ハーブや天然の消化薬の採用など、製品処方の技術的進歩も健康志向の消費者にアピールしています。

市場抑制要因：

大きな成長の可能性があるにもかかわらず、消化器官用治療市場は、厳しい規制要件や、特に下剤や制酸剤といった特定の消化器官用治療の長期使用による副作用への懸念といった課題に直面しています。また、原材料価格の変動や先進的な消化器系治療の中には高価なものもあり、市場成長の抑制要因となっています。さらに、医薬品の消化器官用製品の代替品として自然療法や栄養補助食品を好む傾向が強まっているため、一部の地域では従来の消化器官用治療の成長が制限される可能性があります。こうした課題に対処するため、新興国市場の参入企業は、安全で自然かつ革新的な消化器系健康食品の開発に注力しています。

市場機会：

消化器系治療市場は、特にプロバイオティクスとプレバイオティクスのセグメントで、腸の健康維持に果たす役割が認識されつつあり、いくつかの成長機会をもたらしています。予防医療への関心の高まりに加え、天然材料や植物由来の消化器系ソリューションを求める消費者のニーズは、技術革新と製品開発の大きな機会となります。eコマースセグメントの拡大もまた、市場参入企業がより幅広い消費者層にリーチする機会を提供し、OTC消化薬への容易なアクセスを提供しています。さらに、IBSやクローン病など特定の消化器疾患に対する個別化医療や標的療法への注目の高まりは、市場成長の新たな道を開いています。

本レポートで扱う主要質問

  • 消化薬市場の世界の成長を促進する主要要因は何か？
  • 消化薬セグメントで最も需要が高い製品タイプは？
  • 技術進歩や製品革新は競合情勢にどのような影響を与えているか？
  • 消化器官用治療市場の主要参入企業は誰で、市場の関連性を維持するためにどのような戦略を用いているのか？
  • 消化薬市場の将来を形作る新たな動向と機会は何か？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/ 分類
  • 市場の定義/ 範囲/ 制限

第3章 主要な市場動向

  • 市場に影響を与える主要動向
    • プレバイオティクスの利点に関する消費者の意識向上
    • 小児用消化酵素の需要の高まり
  • 製品イノベーション/開発動向

第4章 重要成功要因

  • 製品の採用/使用状況分析
  • 製品のUSP/特徴

第5章 世界市場-価格分析

  • 地域別価格分析
  • 世界平均価格分析ベンチマーク

第6章 世界市場の需要（価値USD Mn）分析

  • 過去の市場金額（100万米ドル）分析、2019～2023年
  • 現在と将来の市場金額（100万米ドル）予測、2024～2033年
    • 前年比成長動向分析
    • 絶対的収益機会

第7章 市場背景

  • マクロ経済要因
  • 予測要因-関連性と影響
  • バリューチェーン
  • 世界の飲食品業界の展望
  • 世界の製薬業界概要
  • 政策の展開と規制のシナリオ
  • 市場力学
  • 世界需給分析

第8章 製品タイプ別の世界の市場分析

  • イントロダクション
  • 2019～2023年の製品タイプ別市場規模（100万米ドル）と数量分析
  • 現在と将来の市場規模（100万米ドル）と製品タイプ別の数量分析と予測、2024～2033年
    • カプセル
    • 液体/飲料
    • 粉末
    • ジェル
    • その他（錠剤、タブレット、グミ）
  • 製品タイプ別市場の魅力分析

第9章 供給源別の世界の市場分析

  • イントロダクション
  • 2019～2023年の供給源別市場規模（100万米ドル）と数量分析
  • 現在と将来の市場規模（100万米ドル）と供給源別の数量分析と予測、2024～2033年
    • プレバイオティクス
    • プロバイオティクス
    • 食品酵素
  • 供給源別の市場の魅力分析

第10章 性質別の世界の市場分析

  • イントロダクション
  • 2019～2023年の性質別市場規模（100万米ドル）と数量分析
  • 現在と将来の市場規模（100万米ドル）と性質別の数量分析と予測、2024～2033年
    • オーガニック
    • 従来型
  • 性質別市場の魅力分析

第11章 流通チャネル別の世界の市場分析

  • イントロダクション
  • 2019～2023年の流通チャネル別市場規模（100万米ドル）と数量分析
  • 現在と将来の市場規模（100万米ドル）と流通チャネル別の数量分析と予測、2024～2033年
    • 医薬品・ドラッグストア
    • ハイパーマーケット/スーパーマーケット
    • コンビニエンスストア
    • 直営店
    • オンライン小売
    • その他の小売業
  • 流通チャネル別市場の魅力分析

第12章 地域別の世界の市場分析

  • イントロダクション
  • 2019～2023年の地域別市場規模（100万米ドル）と数量分析
  • 現在の市場規模（100万米ドル）と地域別の数量分析と予測、2024～2033年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジアと太平洋
    • 中東・アフリカ
  • 地域別市場の魅力分析

第13章 北米市場分析

第14章 ラテンアメリカ市場分析

第15章 欧州市場分析

第16章 南アジアと太平洋市場分析

第17章 東アジア市場分析

第18章 中東・アフリカ市場分析

第19章 国別市場分析、2024年

  • イントロダクション
  • 米国
  • カナダ
  • メキシコ
  • ブラジル
  • アルゼンチン
  • ドイツ
  • イタリア
  • フランス
  • 英国
  • スペイン
  • ポーランド
  • ロシア
  • 中国
  • 日本
  • 韓国
  • インド
  • オーストラリアとニュージーランド
  • トルコ
  • 南アフリカ

第20章 市場構造分析

  • 企業階層別市場分析（消化薬）
  • 市場集中
  • 市場プレゼンス分析

第21章 競合分析

  • 競合ダッシュボード
  • 競合の詳細
    • Johnson &Johnson, Inc.
    • Bayer AG
    • Sanofi
    • Procter &Gamble Co.
    • Jiangzhong Pharmaceutical Co Ltd
    • Abbott Laboratories Inc.
    • Reckitt Benckiser Group Plc（RB）
    • Takeda Pharmaceutical Co Ltd.
    • Pfizer
    • GlaxoSmithKline Plc
    • Menarini Group
    • Taisho Pharmaceutical Holdings Co Ltd.
    • Purdue Pharma LP
    • Others（Available on Request）

第22章 使用される仮定と頭字語

第23章 調査手法

目次
Product Code: PMRREP30469

Persistence Market Research has recently released a comprehensive report on the worldwide market for digestive remedies. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Digestive Remedies Market Size (2024E): USD 19731.861 Mn
  • Projected Market Value (2033F): USD 28574.426 Mn
  • Global Market Growth Rate (CAGR 2024 to 2033): 4.2 %

Digestive Remedies Market - Report Scope:

Digestive remedies include a broad range of products aimed at treating digestive health issues such as indigestion, acid reflux, constipation, and irritable bowel syndrome (IBS). The market is segmented by product type, including antacids, laxatives, anti-diarrheal drugs, and probiotics, and by end-use sectors such as retail pharmacies, hospital pharmacies, and e-commerce platforms.

Market Growth Drivers:

The global digestive remedies market is driven by rising incidences of digestive disorders and lifestyle diseases, which have led to a surge in demand for over-the-counter (OTC) digestive products. Increasing consumer awareness of gut health and the growing preference for self-medication have also supported the expansion of this market. Aging populations in several regions are more prone to digestive problems, further boosting the demand for digestive remedies. Additionally, the rising consumption of processed foods, sedentary lifestyles, and stress are contributing to the increasing prevalence of digestive issues, driving growth in the market. Technological advancements in product formulations, including the introduction of herbal and natural digestive remedies, are also appealing to health-conscious consumers.

Market Restraints:

Despite significant growth potential, the digestive remedies market faces challenges such as stringent regulatory requirements and concerns about the side effects of long-term use of certain digestive drugs, particularly laxatives and antacids. Fluctuations in raw material prices and the high cost of some advanced digestive treatments also pose limitations to market growth. Furthermore, the growing preference for natural remedies and dietary supplements as alternatives to pharmaceutical digestive products could limit the growth of traditional digestive remedies in some regions. To address these challenges, market players are focusing on developing safe, natural, and innovative digestive health products.

Market Opportunities:

The digestive remedies market presents several growth opportunities, particularly in the area of probiotics and prebiotics, which are increasingly recognized for their role in maintaining gut health. The growing interest in preventive healthcare, along with consumer demand for natural and plant-based digestive solutions, offers significant opportunities for innovation and product development. The expanding e-commerce sector also provides an opportunity for market players to reach a broader consumer base, offering easy access to OTC digestive remedies. Furthermore, the increasing focus on personalized medicine and targeted therapies for specific digestive issues, such as IBS and Crohn's disease, is opening up new avenues for market growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the digestive remedies market globally?
  • Which product types are witnessing the highest demand in the digestive remedies sector?
  • How are technological advancements and product innovations influencing the competitive landscape?
  • Who are the key players in the digestive remedies market, and what strategies are they using to maintain market relevance?
  • What emerging trends and opportunities will shape the future of the digestive remedies market?

Competitive Intelligence and Business Strategy:

Leading players in the global digestive remedies market, including Bayer AG, GlaxoSmithKline Plc, and Johnson & Johnson, are focusing on expanding their product portfolios with a range of digestive health solutions, including both traditional pharmaceuticals and natural remedies. These companies are investing in research and development to create innovative formulations with improved efficacy and fewer side effects. Collaborations with healthcare professionals, pharmacies, and e-commerce platforms are key strategies for promoting digestive remedies to a broader audience. Furthermore, sustainability initiatives, such as eco-friendly packaging and responsible sourcing of natural ingredients, are gaining importance as consumer preferences shift towards more environmentally conscious products.

Companies Covered in This Report

  • Johnson & Johnson, Inc
  • Bayer AG
  • Sanofi
  • Procter & Gamble Co.
  • Jiangzhong Pharmaceutical Co Ltd
  • Abbott Laboratories Inc.
  • Reckitt Benckiser Group Plc (RB)
  • Takeda Pharmaceutical Co Ltd.
  • Pfizer
  • GlaxoSmithKline Plc
  • Menarini Group
  • Taisho Pharmaceutical Holdings Co Ltd.
  • Purdue Pharma LP

Digestive Remedies Industry Research by Category

By Product Type:

  • Capsules
  • Liquid/Drinkable
  • Powder
  • Gels
  • Others(Pills, Tablet, Gummy)

By Nature:

  • Organic
  • Conventional

By Source:

  • Prebiotic
  • Probiotic
  • Food Enzymes

By Sales Channel:

  • Pharmaceutical & Drug Store
  • Hypermarket/Supermarket
  • Convenience Store
  • Direct Store
  • Online Retail
  • Other Retail Format

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Technology Roadmap
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
    • 3.1.1. Increasing Consumer Awareness on Benefits of Prebiotics
    • 3.1.2. High Demand of Pediatric Digestive Enzymes
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption / Usage Analysis
  • 4.2. Product USPs / Features

5. Global Market - Pricing Analysis

  • 5.1. Regional Pricing Analysis
  • 5.2. Global Average Pricing Analysis Benchmark

6. Global Market Demand (in Value US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

  • 6.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 6.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
    • 6.2.1. Y-o-Y Growth Trend Analysis
    • 6.2.2. Absolute $ Opportunity Analysis

7. Market Background

  • 7.1. Macro-Economic Factors
    • 7.1.1. Global GDP Growth Outlook
    • 7.1.2. Global GDP and Infrastructure Investment
    • 7.1.3. International Trade
    • 7.1.4. Global Industry Outlook
  • 7.2. Forecast Factors - Relevance & Impact
    • 7.2.1. Top Companies Historical Growth
    • 7.2.2. GDP Growth forecast
    • 7.2.3. Manufacturing Industry forecast
    • 7.2.4. Global Urbanization Growth Outlook
    • 7.2.5. Business Climate
  • 7.3. Value Chain
    • 7.3.1. Raw Material Suppliers
    • 7.3.2. Product Manufacturers
    • 7.3.3. Application Sectors
  • 7.4. Global Food & Beverage Industry Outlook
  • 7.5. Global Pharmaceutical Industry Overview
  • 7.6. Policy Developments and Regulatory Scenario
  • 7.7. Market Dynamics
    • 7.7.1. Drivers
    • 7.7.2. Restraints
    • 7.7.3. Opportunity Analysis
  • 7.8. Global Supply Demand Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Product Type

  • 8.1. Introduction
  • 8.2. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Product Type, 2024-2033
    • 8.3.1. Capsules
    • 8.3.2. Liquid/Drinkable
    • 8.3.3. Powder
    • 8.3.4. Gels
    • 8.3.5. Others (Pills, Tablet, Gummy)
  • 8.4. Market Attractiveness Analysis By Product Type

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Source

  • 9.1. Introduction
  • 9.2. Historical Market Size (US$ Mn) and Volume Analysis By Source, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Source, 2024-2033
    • 9.3.1. Prebiotic
    • 9.3.2. Probiotic
    • 9.3.3. Food Enzymes
  • 9.4. Market Attractiveness Analysis By Source

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Nature

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) and Volume Analysis By Nature, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Nature, 2024-2033
    • 10.3.1. Organic
    • 10.3.2. Conventional
  • 10.4. Market Attractiveness Analysis By Nature

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Sales Channel

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) and Volume Analysis By Sales Channel, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Sales Channel, 2024-2033
    • 11.3.1. Pharmaceutical & Drug Store
    • 11.3.2. Hypermarket/Supermarket
    • 11.3.3. Convenience Store
    • 11.3.4. Direct Store
    • 11.3.5. Online Retail
    • 11.3.6. Other Retail Format
  • 11.4. Market Attractiveness Analysis By Sales Channel

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2019-2023
  • 12.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2024-2033
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. East Asia
    • 12.3.5. South Asia and Pacific
    • 12.3.6. Middle East and Africa (MEA)
  • 12.4. Market Attractiveness Analysis By Region

13. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 13.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. U.S.
      • 13.3.1.2. Canada
    • 13.3.2. By Product Type
    • 13.3.3. By Source
    • 13.3.4. By Nature
    • 13.3.5. By Sales Channel
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product Type
    • 13.4.3. By Source
    • 13.4.4. By Nature
    • 13.4.5. By Sales Channel
  • 13.5. Drivers and Restraints - Impact Analysis

14. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 14.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Brazil
      • 14.3.1.2. Mexico
      • 14.3.1.3. Argentina
      • 14.3.1.4. Rest of Latin America
    • 14.3.2. By Product Type
    • 14.3.3. By Source
    • 14.3.4. By Nature
    • 14.3.5. By Sales Channel
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product Type
    • 14.4.3. By Source
    • 14.4.4. By Nature
    • 14.4.5. By Sales Channel
  • 14.5. Drivers and Restraints - Impact Analysis

15. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 15.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Germany
      • 15.3.1.2. Italy
      • 15.3.1.3. France
      • 15.3.1.4. U.K.
      • 15.3.1.5. Spain
      • 15.3.1.6. BENELUX
      • 15.3.1.7. Russia
      • 15.3.1.8. Poland
      • 15.3.1.9. Rest of Europe
    • 15.3.2. By Product Type
    • 15.3.3. By Source
    • 15.3.4. By Nature
    • 15.3.5. By Sales Channel
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Product Type
    • 15.4.2. By Source
    • 15.4.3. By Nature
    • 15.4.4. By Sales Channel
  • 15.5. Drivers and Restraints - Impact Analysis

16. South Asia and Pacific Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. ASEAN
      • 16.3.1.3. Oceania
      • 16.3.1.4. Rest of South Asia & Pacific
    • 16.3.2. By Product Type
    • 16.3.3. By Source
    • 16.3.4. By Nature
    • 16.3.5. By Sales Channel
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product Type
    • 16.4.3. By Source
    • 16.4.4. By Nature
    • 16.4.5. By Sales Channel
  • 16.5. Drivers and Restraints - Impact Analysis

17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. China
      • 17.3.1.2. Japan
      • 17.3.1.3. South Korea
    • 17.3.2. By Product Type
    • 17.3.3. By Source
    • 17.3.4. By Nature
    • 17.3.5. By Sales Channel
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product Type
    • 17.4.3. By Source
    • 17.4.4. By Nature
    • 17.4.5. By Sales Channel
  • 17.5. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 18.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. GCC
      • 18.3.1.2. Turkey
      • 18.3.1.3. Nigeria
      • 18.3.1.4. South Africa
      • 18.3.1.5. Rest of Middle East & Africa
    • 18.3.2. By Product Type
    • 18.3.3. By Source
    • 18.3.4. By Nature
    • 18.3.5. By Sales Channel
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product Type
    • 18.4.3. By Source
    • 18.4.4. By Nature
    • 18.4.5. By Sales Channel
  • 18.5. Drivers and Restraints - Impact Analysis

19. Country Wise Market Analysis, 2024

  • 19.1. Introduction
    • 19.1.1. Market Value Proportion Analysis, By Key Countries
    • 19.1.2. Global Vs. Country Growth Comparison
  • 19.2. U.S. Market Analysis
    • 19.2.1. By Product Type
    • 19.2.2. By Source
    • 19.2.3. By Nature
    • 19.2.4. By Sales Channel
  • 19.3. Canada Market Analysis
    • 19.3.1. By Product Type
    • 19.3.2. By Source
    • 19.3.3. By Nature
    • 19.3.4. By Sales Channel
  • 19.4. Mexico Market Analysis
    • 19.4.1. By Product Type
    • 19.4.2. By Source
    • 19.4.3. By Nature
    • 19.4.4. By Sales Channel
  • 19.5. Brazil Market Analysis
    • 19.5.1. By Product Type
    • 19.5.2. By Source
    • 19.5.3. By Nature
    • 19.5.4. By Sales Channel
  • 19.6. Argentina Market Analysis
    • 19.6.1. By Product Type
    • 19.6.2. By Source
    • 19.6.3. By Nature
    • 19.6.4. By Sales Channel
  • 19.7. Germany Market Analysis
    • 19.7.1. By Product Type
    • 19.7.2. By Source
    • 19.7.3. By Nature
    • 19.7.4. By Sales Channel
  • 19.8. Italy Market Analysis
    • 19.8.1. By Product Type
    • 19.8.2. By Source
    • 19.8.3. By Nature
    • 19.8.4. By Sales Channel
  • 19.9. France Market Analysis
    • 19.9.1. By Product Type
    • 19.9.2. By Source
    • 19.9.3. By Nature
    • 19.9.4. By Sales Channel
  • 19.10. U.K. Market Analysis
    • 19.10.1. By Product Type
    • 19.10.2. By Source
    • 19.10.3. By Nature
    • 19.10.4. By Sales Channel
  • 19.11. Spain Market Analysis
    • 19.11.1. By Product Type
    • 19.11.2. By Source
    • 19.11.3. By Nature
    • 19.11.4. By Sales Channel
  • 19.12. Poland Market Analysis
    • 19.12.1. By Product Type
    • 19.12.2. By Source
    • 19.12.3. By Nature
    • 19.12.4. By Sales Channel
  • 19.13. Russia Market Analysis
    • 19.13.1. By Product Type
    • 19.13.2. By Source
    • 19.13.3. By Nature
    • 19.13.4. By Sales Channel
  • 19.14. China Market Analysis
    • 19.14.1. By Product Type
    • 19.14.2. By Source
    • 19.14.3. By Nature
    • 19.14.4. By Sales Channel
  • 19.15. Japan Market Analysis
    • 19.15.1. By Product Type
    • 19.15.2. By Source
    • 19.15.3. By Nature
    • 19.15.4. By Sales Channel
  • 19.16. S. Korea Market Analysis
    • 19.16.1. By Product Type
    • 19.16.2. By Source
    • 19.16.3. By Nature
    • 19.16.4. By Sales Channel
  • 19.17. India Market Analysis
    • 19.17.1. By Product Type
    • 19.17.2. By Source
    • 19.17.3. By Nature
    • 19.17.4. By Sales Channel
  • 19.18. Australia and New Zealand Market Analysis
    • 19.18.1. By Product Type
    • 19.18.2. By Source
    • 19.18.3. By Nature
    • 19.18.4. By Sales Channel
  • 19.19. Turkey Market Analysis
    • 19.19.1. By Product Type
    • 19.19.2. By Source
    • 19.19.3. By Nature
    • 19.19.4. By Sales Channel
  • 19.20. South Africa Market Analysis
    • 19.20.1. By Product Type
    • 19.20.2. By Source
    • 19.20.3. By Nature
    • 19.20.4. By Sales Channel

20. Market Structure Analysis

  • 20.1. Market Analysis by Tier of Companies (Digestive Remedies)
  • 20.2. Market Concentration
  • 20.3. Market Presence Analysis

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Competition Deep Dive
    • 21.2.1. Johnson & Johnson, Inc.
      • 21.2.1.1. Overview
      • 21.2.1.2. Product Portfolio
      • 21.2.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.2.1.4. Sales Footprint
      • 21.2.1.5. Strategy Overview
    • 21.2.2. Bayer AG
      • 21.2.2.1. Overview
      • 21.2.2.2. Product Portfolio
      • 21.2.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.2.2.4. Sales Footprint
      • 21.2.2.5. Strategy Overview
    • 21.2.3. Sanofi
      • 21.2.3.1. Overview
      • 21.2.3.2. Product Portfolio
      • 21.2.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.2.3.4. Sales Footprint
      • 21.2.3.5. Strategy Overview
    • 21.2.4. Procter & Gamble Co.
      • 21.2.4.1. Overview
      • 21.2.4.2. Product Portfolio
      • 21.2.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.2.4.4. Sales Footprint
      • 21.2.4.5. Strategy Overview
    • 21.2.5. Jiangzhong Pharmaceutical Co Ltd
      • 21.2.5.1. Overview
      • 21.2.5.2. Product Portfolio
      • 21.2.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.2.5.4. Sales Footprint
      • 21.2.5.5. Strategy Overview
    • 21.2.6. Abbott Laboratories Inc.
      • 21.2.6.1. Overview
      • 21.2.6.2. Product Portfolio
      • 21.2.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.2.6.4. Sales Footprint
      • 21.2.6.5. Strategy Overview
    • 21.2.7. Reckitt Benckiser Group Plc (RB)
      • 21.2.7.1. Overview
      • 21.2.7.2. Product Portfolio
      • 21.2.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.2.7.4. Sales Footprint
      • 21.2.7.5. Strategy Overview
    • 21.2.8. Takeda Pharmaceutical Co Ltd.
      • 21.2.8.1. Overview
      • 21.2.8.2. Product Portfolio
      • 21.2.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.2.8.4. Sales Footprint
      • 21.2.8.5. Strategy Overview
    • 21.2.9. Pfizer
      • 21.2.9.1. Overview
      • 21.2.9.2. Product Portfolio
      • 21.2.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.2.9.4. Sales Footprint
      • 21.2.9.5. Strategy Overview
    • 21.2.10. GlaxoSmithKline Plc
      • 21.2.10.1. Overview
      • 21.2.10.2. Product Portfolio
      • 21.2.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.2.10.4. Sales Footprint
      • 21.2.10.5. Strategy Overview
    • 21.2.11. Menarini Group
      • 21.2.11.1. Overview
      • 21.2.11.2. Product Portfolio
      • 21.2.11.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.2.11.4. Sales Footprint
      • 21.2.11.5. Strategy Overview
    • 21.2.12. Taisho Pharmaceutical Holdings Co Ltd.
      • 21.2.12.1. Overview
      • 21.2.12.2. Product Portfolio
      • 21.2.12.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.2.12.4. Sales Footprint
      • 21.2.12.5. Strategy Overview
    • 21.2.13. Purdue Pharma LP
      • 21.2.13.1. Overview
      • 21.2.13.2. Product Portfolio
      • 21.2.13.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.2.13.4. Sales Footprint
      • 21.2.13.5. Strategy Overview
    • 21.2.14. Others (Available on Request)
      • 21.2.14.1. Overview
      • 21.2.14.2. Product Portfolio
      • 21.2.14.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.2.14.4. Sales Footprint
      • 21.2.14.5. Strategy Overview

22. Assumptions and Acronyms Used

23. Research Methodology